Results of AZALEA and ARTESiA Trials of Afib Stroke Prevention Presented at AHA

This month, at the American Heart Association Scientific Sessions held in Philadelphia, several important Afib Late-Breaking Clinical Trials were presented that I want to share with you. These include AZALEA, ARTESiA, and NOAH-AFNET 6. We have posted news stories about them, which you can access here:

Afib News from the American Heart Association Scientific Sessions 2023

P.S. With Giving Tuesday coming up tomorrow, we welcome your support if you’re so inclined. You can donate using the red Donate button at the top of the page at StopAfib.org (or go directly to our donate page at https://fundraise.givesmart.com/form/Z74aUQ).